Health
Heparin targets coronavirus spike protein, research shows – Newswise
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant
Newswise — An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus’ ability to attach to human cells and infect them.
The research, published in the journals British Journal of Pharmacology, and Thrombosis and Haemostasis, found that heparin interacts with the spike protein on the surface of coronavirus (SARS-CoV2),…
Continue Reading
